Correction To: Metformin Ameliorates Scleroderma Via Inhibiting Th17 Cells and Reducing MTOR-STAT3 Signaling in Skin Fibroblasts

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2021 Jun 22

PMID 34154617

Citations 1

Authors

Jeonghyeon Moon

Seon-Yeong Lee

Jeong Won Choi

A Ram Lee

Jin Hee Yoo

Su-Jin Moon

Sung-Hwan Park

Mi-La Cho

Affiliations

Soon will be listed here.

Citing Articles

Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis.

Shen C, Lu C, Wu C, Li K, Kuo Y, Hsieh S Cells. 2021; 10(12).

PMID: 34943909 PMC: 8699891. DOI: 10.3390/cells10123402.

References

Moon J, Lee S, Choi J, Lee A, Yoo J, Moon S . Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. J Transl Med. 2021; 19(1):192. PMC: 8097822. DOI: 10.1186/s12967-021-02860-z. View